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No clear boundary between placebo and effective treatment
In a recent editorial, Justman 1 discussed the use of placebos in clinical practice. Of all the GPs who used pure placebos, fewer than one in ten reported that they explained to the patient that they were prescribing a placebo, according to a study by Howick et al. 2 According to the same study GPs also disapproved of deception. Justman 1 suggested that GPs might well be inconsistent by disapproving of deception and not telling patients that they are prescribed a placebo.
Howick et al. 2 made a difference between pure placebos (such as sugar-coated pills) and impure placebos (such as peppermint pills). However, there is no sharp dividing line between pure placebo, impure placebo and active treatment. The word 'placebo response' is a misnomer, because a therapeutic response to an effective treatment can consist of a placebo component. 3 Research into depression suggests that patients sometimes respond to pure placebos and this correlates with changes in brain physiology. 4 One can wonder whether one of the examples of impure placebos from Howick's study, 2 peppermint pills, really has no genuine therapeutic effects for pharyngitis, although it is probably the sucking on the pills and not the peppermint. Because there is no sharp dividing line between placebo and active treatment, it is more useful to think about placebo as a form of treatment, which can be effective for some conditions such as depression and not for others such as cancer.
Practising doctors face a dilemma. They have to install hope, that the treatment will work and at the same time they have to give accurate information 5 about advantages and disadvantages of the proposed treatment. Mentioning the word placebo can be counterproductive, and it is not necessarily deception, if the word placebo is not used, given that even pure placebos can correlate with changes in the brain.
Speech deficits as plot devices in novels
P Perkins 1 appears to have misunderstood the key messages of our paper 'Neurological speech deficits as plot devices in novels' 2 entirely. We pointed out that, unsurprisingly, characters with stroke commonly appear in novels. In each novel discussed the fact that a key protagonist had suffered a speech deficit, presumably as a result of a stroke, significantly altered the plot of the novel. In discussing the various characters, we suggested some possibilities for the speech disorder but we were not seeking to make precise diagnoses. The influence on the novel's plot and not the diagnosis of the speech deficit was our point of interest.
We disagree with Perkins' apparent suggestion that medical diagnosis and treatment in novels should be confined to fictional doctors or medically qualified authors and fail to see how the number of medical references in Conan Doyle's work has any relevance to our paper. As RS Downie points out, there are a variety of ways in which literature has influenced medicine and vice versa. 3 Literature can also remind us that what is scientifically typical appears in unique forms in individual patients. 3 It would be a dull world indeed if medical matters in literature were confined to doctors, real or fictionary, alone. One of the joys of reading the JRSM over many years has been the wide variety of discussions and interpretations of medicine in literature. Long may that continue.
